Literature DB >> 2417696

Histologic assessment of resected hepatocellular carcinoma after transcatheter hepatic arterial embolization.

H C Hsu, T C Wei, Y M Tsang, M Z Wu, Y H Lin, S M Chuang.   

Abstract

Ten cases of large hepatocellular carcinoma (HCC) (largest diameter, 6.5-15 cm) were surgically resected from 3 to 19 days after transcatheter hepatic arterial embolization (TAE) for histologic assessment of the effectiveness. Another two patients, including one with a small HCC (3.5 X 3 X 3 cm) who died of complications, were also studied. The patients' ages ranged from 20 to 64 years, 11 were men and 1 was a woman, and all positive for serum hepatitis B surface antigen. All 11 cases with large HCC were symptomatic before the HCC was clinically diagnosed. Alpha-fetoprotein levels were elevated in ten cases but immediately dropped to normal levels after TAE and resection in eight cases. An effective massive tumor coagulative necrosis of 99% already occurred 3 days after TAE. A necrosis involving more than 95% of the whole tumor mass was demonstrated in eight cases: one was a large HCC taken from an autopsy specimen, and TAE was done three times. This strongly indicates the effectiveness of TAE on the destruction of HCC. However, the presence of viable residual tumors in 11 cases also strongly argues for the necessity for surgical resection whenever it is possible. The failure of a complete necrosis was related to the extracapsular extension, liver invasion, satellite nodules, and portal vein involvement, and probably related to collateral and portal vein blood supply.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2417696     DOI: 10.1002/1097-0142(19860315)57:6<1184::aid-cncr2820570620>3.0.co;2-9

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  15 in total

1.  Hepatic perfusion changes after transcatheter arterial embolization (TAE) of hepatocellular carcinoma: measurement by dynamic computed tomography (CT).

Authors:  Y Tsushima; Y Unno; J Koizumi; S Kusano
Journal:  Dig Dis Sci       Date:  1998-02       Impact factor: 3.199

2.  Effects of transcatheter arterial chemoembolization with oral chemotherapy on hepatic neoplasms.

Authors:  N Hashimoto; S Kawai; S Mikuriya; T Oda; J Inoue; Y Shimamura; A Takahashi; M Masuzawa; Y Yumoto; M Makino
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

3.  Transcatheter arterial chemoembolization in patients with hepatocellular carcinoma and coexisting hepatic cavernous hemangioma.

Authors:  Ran-Chou Chen; Jiunn-Ming Lii; Wei-Tsung Chen; Hsing-Yang Tu; Liang-Chung Chiang
Journal:  Eur Radiol       Date:  2005-12-06       Impact factor: 5.315

4.  Retrospective evaluation of tumor-mass-reduction therapy for the prognosis of recurrent hepatocellular carcinoma.

Authors:  Emiko Mikami; Noriatsu Kanno; Yoshiyuki Ueno; Tooru Shimosegawa
Journal:  Hepatol Int       Date:  2007-10-18       Impact factor: 6.047

5.  [Regression and therapy-resistance of primary liver tumors and liver metastases after regional chemotherapy and local tumor ablation].

Authors:  H-P Fischer
Journal:  Pathologe       Date:  2005-05       Impact factor: 1.011

6.  Clinicopathological study on combination therapy consisting of arterial infusion of lipiodol-dissolved SMANCS and transcatheter arterial embolization for hepatocellular carcinoma.

Authors:  K Jinno; S Moriwaki; M Tanada; T Wada; K Mandai; Y Okada
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

7.  Efficacy of combination treatment--(TAE with adriamycin and ethanol)--for hepatocellular carcinoma.

Authors:  Y Hasuike; J Okamura; J Furukawa; M Naoi; N Takata; H Maruyama; M Kinuta; E Yayoi; H Oi; S Okamoto
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

8.  Hepatocellular carcinoma with adjacent organ extension: the enhancement of preoperative transcatheter arterial embolization and the results of surgical resection.

Authors:  C C Wu; W L Ho; T J Liu
Journal:  Surg Today       Date:  1994       Impact factor: 2.549

9.  Predictive factors of tumor response to trans-catheter treatment in cirrhotic patients with hepatocellular carcinoma: a multivariate analysis of pre-treatment findings.

Authors:  Roberto Miraglia; Giada Pietrosi; Luigi Maruzzelli; Ioannis Petridis; Settimo Caruso; Gianluca Marrone; Giuseppe Mamone; Giovanni Vizzini; Angelo Luca; Bruno Gridelli
Journal:  World J Gastroenterol       Date:  2007-12-07       Impact factor: 5.742

10.  Transcatheter arterial embolization followed by percutaneous ethanol injection in the treatment of hepatocellular carcinoma.

Authors:  R Lencioni; C Vignali; D Caramella; R Cioni; S Mazzeo; C Bartolozzi
Journal:  Cardiovasc Intervent Radiol       Date:  1994 Mar-Apr       Impact factor: 2.740

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.